Mechanisms of glucocorticoid-induced osteoporosis.

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753

Use of Inhaled Corticosteroids and Risk of Fractures

van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297

Use of oral corticosteroids and risk of fractures

Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263

Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene

Tanaka, T., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7432 · Cited by 804

Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1

Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794

Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas

Freije, J. M. P., Diez‐Itza, I., Balbı́n, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otı́n, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 757

Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation

Knäuper, V., Will, H., López-Otı́n, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17124 · Cited by 747

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705

Induction of Peroxisome Proliferator-Activated Receptor γ during the Conversion of 3T3 Fibroblasts into Adipocytes Is Mediated by C/EBPβ, C/EBPδ, and Glucocorticoids

Wu, Z., Bucher, N. L. R., & Farmer, S. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4128 · Cited by 619

Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease

Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824

Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover

Cheng, C.-H., Chen, L.-R., & Chen, K.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031376 · Cited by 595

MANAGEMENT OF ENDOCRINE DISEASE: Secondary osteoporosis: pathophysiology and management

Mirza, F., & CANALIS, E. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0118 · Cited by 343

Osteoblast physiology in normal and pathological conditions

Neve, A., Corrado, A., & Cantatore, F. P. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1086-1 · Cited by 354

Bioresponsive drug delivery systems for the treatment of inflammatory diseases

Dou, Y., Li, C., Li, L., Guo, J., & Zhang, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.008 · Cited by 226

Reactive Oxygen Species Responsive Theranostic Nanoplatform for Two-Photon Aggregation-Induced Emission Imaging and Therapy of Acute and Chronic Inflammation

Ma, B., Xu, H., Zhuang, W., Wang, Y., Li, G., & Wang, Y. (2020) · ACS Nano · doi:10.1021/acsnano.0c01012 · Cited by 176

Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview

Wang, L.-T., Chen, L.-R., & Chen, K.-H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065814 · Cited by 168

Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma

Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Biondi, B., Iorio, S., Giustina, A., Amato, G., & Carella, C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041126 · Cited by 126

Cyclodextrin‐Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases

Guo, J., Li, D., Tao, H., Li, G., Liu, R., Dou, Y., Jin, T., Li, L., Huang, J., Hu, H., et al. (2019) · Advanced Materials · doi:10.1002/adma.201904607 · Cited by 110

Polymeric particle-based therapies for acute inflammatory diseases

Brannon, E. R., Guevara, M. V., Pacifici, N. J., Lee, J. K., Lewis, J. S., & Eniola‐Adefeso, O. (2022) · Nature Reviews Materials · doi:10.1038/s41578-022-00458-5 · Cited by 103

Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial

STOCH, S. A., SAAG, K. G., GREENWALD, M., SEBBA, A. I., COHEN, S., VERBRUGGEN, N., GIEZEK, H., WEST, J., & SCHNITZER, T. J. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081207 · Cited by 100

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes

Gado, M., Baschant, U., Hofbauer, L. C., & Henneicke, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835720 · Cited by 95

Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation

Hamidouche, Z., Fromigué, O., Ringe, J., Häupl, T., & Marie, P. J. (2010) · BMC Cell Biology · doi:10.1186/1471-2121-11-44 · Cited by 92

Impaired Cortical Bone Acquisition and Osteoblast Differentiation in Mice with Osteoblast-Targeted Disruption of Glucocorticoid Signaling

Sher, L. B., Harrison, J. R., Adams, D. J., & Kream, B. E. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0297-z · Cited by 79

Early and Severe Hyperparathyroidism Associated with Hypercalcemia After Renal Transplant Treated with Cinacalcet

Leca, N., Laftavi, M. R., Gundroo, A. A., Kohli, R. K., Min, I., Karam, J. S., Sridhar, N. R., Blessios, G. A., Venuto, R. C., & PANKEWYCZ, O. G. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01475.x · Cited by 79

Posttransplantation Bone Disease

Cunningham, J. (2005) · Transplantation · doi:10.1097/01.tp.0000149698.79739.ef · Cited by 79

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial

Lems, W. F., Lodder, M. C., Lips, P. T. A. M., Bijlsma, J. W. J., Geusens, P., Schrameijer, N., van de Ven, C. M., & Dijkmans, B. A. C. (2006) · Osteoporosis International · doi:10.1007/s00198-005-0037-2 · Cited by 76

Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.

de Nijs, R. N. J. (2008) · PubMed · Cited by 74

Extrinsic Mechanisms Involved in Age-Related Defective Bone Formation

Marie, P. J., & Kassem, M. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2113 · Cited by 78

Management of mineral and bone disorder after kidney transplantation

Kalantar‐Zadeh, K., Molnar, M. Z., Kovesdy, C. P., Mucsi, I., & Bunnapradist, S. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283546ee0 · Cited by 73

Histomorphometric analysis of glucocorticoid-induced osteoporosis

Carbonare, L. D., Bertoldo, F., Valenti, M. T., Zenari, S., Zanatta, M., Sella, S., Giannini, S., & Cascio, V. L. (2005) · Micron · doi:10.1016/j.micron.2005.07.009 · Cited by 71

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study

Engvall, I.-L., Svensson, B., Tengstrand, B., Brismar, K., Hafström, I., & the BARFOT study group (2008) · Arthritis Research & Therapy · doi:10.1186/ar2542 · Cited by 65

Alendronate Protects Premenopausal Women from Bone Loss and Fracture Associated with High-dose Glucocorticoid Therapy

Okada, Y., Nawata, M., Nakayamada, S., Saito, K., & Tanaka, Y. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080168 · Cited by 59

Effect of Pamidronate on Bone Loss After Kidney Transplantation: A Randomized Trial

Walsh, S. B., Altmann, P., Pattison, J. M., Wilkie, M. E., Yaqoob, M. M., Dudley, C. R. K., Cockwell, P., Sweny, P., Banks, L. M., Hall-Craggs, M. A., et al. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.11.036 · Cited by 58

The effects of hormonal contraceptives on bone turnover markers and bone health

Herrmann, M., & Seibel, M. J. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03688.x · Cited by 58

Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials

Shih, Y.-R. V., & Varghese, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.005 · Cited by 58

IDO activation, inflammation and musculoskeletal disease

Ogbechi, J., Clanchy, F. I. L., Huang, Y.-S., Topping, L. M., Stone, T. W., & Williams, R. O. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110820 · Cited by 57

Glucocorticoid-induced osteoporosis

Tamura, Y., Okinaga, H., & Takami, H. E. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.08.018 · Cited by 56

High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment

Amato, G., Mazziotti, G., Sorvillo, F., Piscopo, M., Lalli, E., Biondi, B., Iorio, S., Molinari, A. M., Giustina, A., & Carella, C. (2004) · Bone · doi:10.1016/j.bone.2004.04.021 · Cited by 53

Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway

Yang, F., Lin, Z. W., Huang, T., Chen, T. T., Cui, J., Li, M. Y., & Hua, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-43518-7 · Cited by 51

Medical treatment of vertebral osteoporosis

Lippuner, K. (2003) · European Spine Journal · doi:10.1007/s00586-003-0608-x · Cited by 49

Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats

Bitto, A., Polito, F., Burnett, B. P., Levy, R. M., Stefano, V. D., Armbruster, M. A., Marini, H. R., Minutoli, L., Altavilla, D., & Squadrito, F. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0552 · Cited by 48

Osteoblast Role in Rheumatic Diseases

Corrado, A., Maruotti, N., & Cantatore, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061272 · Cited by 41

Prevalence and risk factors of vertebral compression fractures in female SLE patients

Almehed, K., Hetenyi, S., Ohlsson, C., Carlsten, H., & Forsblad‐d’Elia, H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3104 · Cited by 43

Pathogenesis and Prevention of Bone Loss in Patients Who Have Kidney Disease and Receive Long-Term Immunosuppression

Cunningham, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050427 · Cited by 44

Risk Assessment of Immunosuppressive Therapy in Facial Transplantation

Vasilic, D., Alloway, R. R., Barker, J. H., Furr, A., Ashcroft, R., Banis, J. C., Kon, M., & Woodle, E. S. (2007) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000270316.33293.ec · Cited by 43

Mineral and bone disorder after kidney transplantation

Taweesedt, P. T. (2015) · World Journal of Transplantation · doi:10.5500/wjt.v5.i4.231 · Cited by 42

Requirement of a bone morphogenetic protein for the maintenance and stimulation of osteoblast differentiation

Martinović, S., Borovečki, F., Miljavac, V., Kišić, V., Matičić, D., Francetić, I., & Vukičević, S. (2006) · Archivum histologicum japonicum · doi:10.1679/aohc.69.23 · Cited by 41

Vitamin D in nephrotic syndrome remission: a case–control study

Banerjee, S., Basu, S., & Sengupta, J. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2511-y · Cited by 39

Osteoporosis in inflammatory bowel disease

Reinshagen, M. (2008) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2008.01.005 · Cited by 39

Childhood Osteoporosis

Khoshhal, K. I. (2011) · Journal of Taibah University Medical Sciences · doi:10.1016/s1658-3612(11)70168-8 · Cited by 33

Inflammatory Bowel Disease and Risk of Osteoporotic Fractures: A Meta-Analysis

Hidalgo, D. F., Boonpheng, B., Phemister, J., Hidalgo, J., & Young, M. (2019) · Cureus · doi:10.7759/cureus.5810 · Cited by 33

Update on pediatric bone health.

Henwood, M. J., & Binkovitz, L. A. (2009) · PubMed · Cited by 33

Bone-brain interaction: mechanisms and potential intervention strategies of biomaterials

Yu, J., Ji, L., Liu, Y., Wang, X., Wang, J., & Liu, C. (2025) · Bone Research · doi:10.1038/s41413-025-00404-5 · Cited by 34

Col3.6-HSD2 transgenic mice: A glucocorticoid loss-of-function model spanning early and late osteoblast differentiation

Yang, M., Trettel, L. B., Adams, D. J., Harrison, J. R., CANALIS, E. M., & Kream, B. E. (2010) · Bone · doi:10.1016/j.bone.2010.06.002 · Cited by 32

Bone health in pediatric patients with neurological disorders

Ko, A., Kong, J., Samadov, F., Mukhamedov, A., Kim, Y. M., Lee, Y. J., & Nam, S. O. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2020.25.1.15 · Cited by 32

Diurnal cortisol profiles, inflammation, and functional limitations in aging: Findings from the MIDUS study.

Piazza, J. R., Dmitrieva, N., Charles, S. T., Almeida, D. M., & Orona, G. A. (2018) · Health Psychology · doi:10.1037/hea0000629 · Cited by 37

Drug and Hormone Effects on Vitamin D Metabolism

Emkey, G. R., & Epstein, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00075-4 · Cited by 27

A Study to Evaluate the Cause of Bone Demineralization in Gynecological Cancer Survivors

Stavraka, C., Maclaran, K., Gabra, H., Agarwal, R., Ghaem‐Maghami, S., Taylor, A., Dhillo, W. S., Panay, N., & Blagden, S. P. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0416 · Cited by 27

6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis

Schanoski, A. S., Goméz-Piña, V., del Fresno, C., Rodríguez-Rojas, A., García, F., Glaría, A., Sánchez, M., Vallejo‐Cremades, M. T., Baos, R., Fuentes‐Prior, P., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106673 · Cited by 27

Cross-sectional Study of Bisphosphonate Use in Dermatology Patients Receiving Long-term Oral Corticosteroid Therapy

Liu, R. H., Albrecht, J., & Werth, V. P. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.1.37 · Cited by 27

Glucocorticoids in spondyloarthritis—systematic review and real-world analysis

Dhir, V., Mishra, D., & Samanta, J. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab275 · Cited by 26

TNF-Polarized Macrophages Produce Insulin-like 6 Peptide to Stimulate Bone Formation in Rheumatoid Arthritis in Mice

Yi, X., Liu, X., Kenney, H. M., Duan, R., Lin, X., Schwarz, E. M., & Yao, Z. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4447 · Cited by 23

Large increases in adipose triacylglycerol flux in Cushingoid CRH-Tg mice are explained by futile cycling

Harris, C. A., Roohk, D. J., Fitch, M. D., Boudignon, B. M., Halloran, B. P., & Hellerstein, M. K. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00154.2012 · Cited by 24

Bone mineral density in children with idiopathic nephrotic syndrome

El-Mashad, G. M., El‐Hawy, M. A., El-Hefnawy, S. M., & Mohamed, S. M. (2016) · Jornal de Pediatria · doi:10.1016/j.jped.2016.05.010 · Cited by 24

Effect of D-003, a Mixture of Very High Molecular Weight Aliphatic Acids, on Prednisolone-Induced Osteoporosis in Sprague-Dawley Rats

Noa, M., Mendoza, S., s, R. M., Mendoza, N., & Le??n, F. (2004) · Drugs in R&D · doi:10.2165/00126839-200405050-00004 · Cited by 23

Protein Deficiency and Nematode Infection during Pregnancy and Lactation Reduce Maternal Bone Mineralization and Neonatal Linear Growth in Mice ,

Odiere, M. R., Scott, M. E., Weiler, H. A., & Koski, K. G. (2010) · Journal of Nutrition · doi:10.3945/jn.110.125013 · Cited by 21

Bone disease after kidney transplantation

Mitterbauer, C., & Oberbauer, R. W. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00665.x · Cited by 21

Expression regulation and functional analysis of RGS2 and RGS4 in adipogenic and osteogenic differentiation of human mesenchymal stem cells

Madrigal, A., Tan, L., & Zhao, Y. (2017) · Biological Research · doi:10.1186/s40659-017-0148-1 · Cited by 20

Preventive effects of Polygonum multiflorum on glucocorticoid-induced osteoporosis in rats

Zhou, M., Li, J., Wu, J., Yang, Y., Zeng, X., Lv, X., Cui, L., Yao, W., & Liu, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4802 · Cited by 20

Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease

Oshagbemi, O. A., Burden, A. M., Shudofsky, K. N., Driessen, J. H. M., Vestergaard, P., Krings, A., Franssen, F. M. E., van den Bergh, J. P., & de Vries, F. (2018) · Bone · doi:10.1016/j.bone.2018.02.007 · Cited by 18

The glucocorticoid receptor agonistic modulators CpdX and CpdX-D3 do not generate the debilitating effects of synthetic glucocorticoids

Hua, G., Zein, N., Paulen, L., & Chambon, P. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908264116 · Cited by 19

Differential In Vivo Effects on Target Pathways of a Novel Arylpyrazole Glucocorticoid Receptor Modulator Compared with Prednisolone

Roohk, D. J., Varady, K. A., Turner, S., Emson, C. L., Gelling, R. W., Shankaran, M., Lindwall, G., Shipp, L. E., Scanlan, T. S., Wang, J.-C., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162487 · Cited by 17

The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis

Deng, J., Silver, Z. A., Huang, E., Zheng, E., Kavanagh, K., & Panicker, J. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05294-y · Cited by 17

Is the glucocorticoid receptor a key player in prostate cancer?: A literature review

Sakellakis, M., & Flores, L. J. (2022) · Medicine · doi:10.1097/md.0000000000029716 · Cited by 17

Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease

Kikuchi, Y., Imakiire, T., Yamada, M., Saigusa, T., Hyodo, T., Kushiyama, T., Higashi, K., Hyodo, N., Yamamoto, K., Suzuki, S., et al. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl568 · Cited by 18

Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

Kananen, K., Volin, L., Laitinen, K., Ruutu, T., & Välimäki, M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-0040-7 · Cited by 16

Balancing Altered Calcium Metabolism with Bone Health in Sarcoidosis

Zhou, Y. F., & Lower, E. E. (2020) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0040-1713009 · Cited by 16

Low bone-mineral density in patients with HIV: pathogenesis and clinical significance

Yin, M. T., & Shane, E. J. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/med.0b013e3280109b6c · Cited by 15

The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells

Hong, D., Chen, H., Ge, R., & Li, J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.06.015 · Cited by 15

Interrelationships between Morphometric, Densitometric, and Mechanical Properties of Mandible in 6-month-old Male Pigs

Tymczyna, B., Bachanek, T., Tatara, M. R., Krupski, W., Tymczyna-Sobotka, M., & Łuszczewska‐Sierakowska, I. (2012) · Journal of Veterinary Research · doi:10.2478/v10213-012-0032-2 · Cited by 15

Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes

El‐Jawhari, J. J., Ganguly, P., Jones, E., & Giannoudis, P. V. (2021) · Bioengineering · doi:10.3390/bioengineering8050069 · Cited by 15

Modified Qing’ e Pills exerts anti-osteoporosis effects and prevents bone loss by enhancing type H blood vessel formation

Lu, J., Hu, D., Ma, C., Xu, X., Shen, L., Rong, J., Zhao, J., & Shuai, B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.998971 · Cited by 14

Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats.

Ahmed, H. H., Morcos, N. Y. S., Eskander, E. F., Seoudi, D. M., & Shalby, A. B. (2012) · PubMed · Cited by 14

Calcium and Bone Metabolism Pre- and Post-Kidney Transplantation

Hamdy, N. A. T. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.009 · Cited by 14

Efficacy of a step-down regimen of oral prednisolone in axial spondyloarthritis: result of a double-blind randomized controlled trial (COBRA-AS Study)

Mishra, D., Dhir, V., Naidu, G., Khullar, A., Kumar, V., Sharma, S., Sharma, A., & Jain, S. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa685 · Cited by 13

Glucocorticoid-induced osteoporosis: skeletal manifestations of glucocorticoid use and 2004 Japanese Society for Bone and Mineral Research-proposed guidelines for its management

Soen, S., & Tanaka, Y. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0391-0 · Cited by 13

Bone Disease in Renal Transplantation and Pleotropic Effects of Vitamin D Therapy

Sikgenc, M. M., Paydaş, S., Balal, M., Demir, E., Kurt, C., Sertdemır, Y., Binokay, F., & Erken, U. (2010) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.04.054 · Cited by 13

Causal diagramming for assessing human system risk in spaceflight

Antonsen, E., Reynolds, R. J., Charvat, J. M., Connell, E., Monti, A., Petersen, D., Nartey, N., Anton, W., Abukmail, A., Marotta, K., et al. (2024) · npj Microgravity · doi:10.1038/s41526-024-00375-7 · Cited by 12

Glucocorticoids Alter Bone Microvascular Barrier via MAPK/Connexin43 Mechanisms

Lee, E. J., Lialios, P., Curtis, M., Williams, J. K., Kim, Y., Salipante, P. F., Hudson, S. D., Esch, M. B., Levi, M., Kitlinska, J. B., et al. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404302 · Cited by 14

Capturing microscopic features of bone remodeling into a macroscopic model based on biological rationales of bone adaptation

Kim, Y. K., KAMEO, Y., Tanaka, S., & ADACHI, T. (2017) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-017-0914-6 · Cited by 12

Effects of glucocorticoid treatment on bone strength

Manolides, A. S., Cullen, D. M., & Akhter, M. P. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0156-5 · Cited by 12

Prevalence of Musculoskeletal Manifestations in Adult Kidney Transplant’s Recipients: A Systematic Review

Hassan, A. B., Ghalib, K. W., Jahrami, H., & El‐Agroudy, A. E. (2021) · Medicina · doi:10.3390/medicina57060525 · Cited by 11

Genetic regulation of bone mass: from bone density to bone strength

Langman, C. B. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1687-6 · Cited by 11

Revolutionizing IBD therapy: Insights into contemporary treatment strategies

Kushwaha, P., Qureshi, R., Khan, N., & Mukhopadhyay, S. (2025) · International Reviews of Immunology · doi:10.1080/08830185.2025.2563522 · Cited by 12

Drug and Hormone Effects on Vitamin D Metabolism

Epstein, S., & Schneider, A. E. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50077-2 · Cited by 9

Serum osteoprotegerin and soluble receptor activator of nuclear factor κB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study

Giusti, M., Cecoli, F., Fazzuoli, L., Franchis, V. D., Ceresola, E., Ferone, D., Mussap, M., & Minuto, F. M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.004 · Cited by 9

Establishing Digital Biomarkers for Occupational Health Assessment in Commercial Salmon Fishermen: Protocol for a Mixed-Methods Study

Wilbur, R. E., Griffin, J. S., Sorensen, M., & Furberg, R. (2018) · JMIR Research Protocols · doi:10.2196/10215 · Cited by 7

A meta-analysis of the risk of osteoporotic fractures in inflammatory bowel disease

Hao, L., Mu, S., Yin, J., & Liu, J. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/168684 · Cited by 7

Risedronate Therapy for the Prevention of Steroid-induced Osteoporosis in Patients with Minimal-change Nephrotic Syndrome

Takei, T., Itabashi, M., Tsukada, M., Sugiura, H., Moriyama, T., Kojima, C., Shiohira, S., Shimizu, A., Karasawa, K., Amemiya, N., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3707 · Cited by 7

Glucocorticoid-induced osteoporosis in premenopausal women: management for the rheumatologist

Chakrabarti, K., & McCune, W. J. (2023) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000934 · Cited by 7

What Is New in the Treatment of Steroid-Induced Osteoporosis?

Liu, R. H., & Werth, V. P. (2006) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2006.04.003 · Cited by 7

Zoledronate and lipopolysaccharide suppress osteoblast differentiation through downregulating phosphorylation of Smad in pre-osteoblastic MC3T3-E1 cells

Amamoto, S., Yoshiga, D., Tabe, S., Kokabu, S., Fujii, W., Hikiji, H., Tominaga, K., & Yoshioka, I. (2022) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2022.01.007 · Cited by 6

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids

Atilano-Miguel, S., Barbosa-Cortés, L., & Ortiz, R. (2022) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.21000171 · Cited by 6

Symptomatic Hypercalcemia Due to Painless Thyroiditis after Unilateral Adrenalectomy in a Patient with Cushing's Syndrome

Kimura, H., Sato, K., Nishimaki, M., Miki, N., Ono, M., & Takano, K. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0616 · Cited by 6

Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy

Cosentini, D., Grisanti, S., Hadoux, J., Libé, R., Frigerio, M., Laganà, M., Deschamps, F., Zamparini, M., Lamartina, L., Pedersini, R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab899 · Cited by 6

Osteoblasts and their Signaling Pathways

Lian, J. B., Gravallese, E. M., & Stein, G. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10005-6 · Cited by 5

Hepatocyte Growth Factor in Normal and Diseased Bone and Joint Tissues

Adamopoulos, I. E., & Athanasou, N. A. (2006) · Current Rheumatology Reviews · doi:10.2174/157339706775697017 · Cited by 6

Functional Recovery and Length of Stay After Hip Fracture in Patients Taking Corticosteroids

Monaco, M. D., Vallero, F., Monaco, R. D., Mautino, F., & Cavanna, A. (2004) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000133438.80033.41 · Cited by 6

Incidence and risk factors of subsequent vertebral fracture following percutaneous vertebral augmentation in postmenopausal women

Cheng, Y., Chen, X., Li, Y., Tan, Z., Yao, X., Jiang, R., & Wu, H. (2024) · European Spine Journal · doi:10.1007/s00586-024-08331-5 · Cited by 5

Mechanisms of glucocorticoid action in bone

CANALIS, E. M. (2005) · Current Osteoporosis Reports · doi:10.1007/s11914-005-0017-7 · Cited by 160

Mechanisms of glucocorticoid action in bone cells

Delany, A. M., Dong, Y., & CANALIS, E. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240560304 · Cited by 134

Glucocorticoids and Osteoporosis

Reid, I. R. (1999) · Elsevier eBooks · doi:10.1016/b978-012528640-4/50021-6 · Cited by 5

Glucocorticoid-induced osteoporosis

CANALIS, E. M. (2000) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200012000-00005 · Cited by 16

Elucidating the role of the glucocorticoid receptor in glucocorticoid-induced osteoporosis

Warde, N. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.130